Catelani Michael bought ANIX
January 15, 2025 · Form 4 insider transaction
Catelani Michael bought 9,289 shares of Anixa Biosciences, Inc. at $2.15 per share, a transaction worth $20.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,289
Price
$2.15
Total value
$20.0K
InsiderCatelani Michael
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJanuary 15, 2025
Filing dateJanuary 15, 2025
Shares owned after44,500
OwnershipDirect
10b5-1 planNo
AmendedNo